Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements☆
References (50)
- et al.
Efficacy of amiodarone for refractory supraventricular tachyarrhythmias
Am Heart J
(1983) - et al.
Amiodarone for control of sustained ventricular tachyarrhythmia: Clinical and electrophysiologic effects in 51 patients
Am J Cardiol
(1982) - et al.
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone
Am Heart J
(1981) - et al.
Prospective evaluation of amiodarone pulmonary toxicity
Chest
(1984) - et al.
Ventricular flutter during treatment with amiodarone
Am J Cardiol
(1983) - et al.
Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements
J Am Coll Cardiol
(1986) - et al.
Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs
Am Heart J
(1979) - et al.
Effect of quinidine and bretylium on defibrillation energy requirements
Am Heart J
(1986) - et al.
The effects of cardiovascular drugs on the defibrillation threshold and the pathological effects on the heart using an automatic implantable defibrillator
Ann Thorac Surg
(1983) Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs
Am Heart J
(1978)
The relationship between successful defibrillation and delivered energy in open-chest dogs: Reappraisal of the “defibrillation threshold” concept
Am Heart J.
(1987)
The implanted defibrillator: Relation of defibrilation threshold
J Am Coll Cardol
(1985)
Malignant ventricular tachyarrhythmias associated with the use of encainide
Am Heart J
(1981)
Ventricular fibrillation in a conscious canine preparation of sudden coronary death—prevention by short- and long-term amiodarone administration
Circulation
(1983)
Prognosis after sudden cardiac death without associated myocardial infarction: One year follow-up of empiric therapy with amiodarone
Am Heart J
(1984)
Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone
J Am Coll Cardiol
(1986)
Clinical use and pharmacology of amiodarone
Med Clin North Am
(1984)
Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects
J Am Coll Cardiol
(1984)
A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient
Circulation
(1984)
Electrophysiologic effects of amiodarone: Experimental and clinical observation relative to serum and tissue drug concentrations
Am Heart J
(1984)
Pharmacodynamics of intravenous amiodarone in the dog
J Cardiovasc Pharmacol
(1984)
Clinical efficacy of amiodarone as an antiarrhythmic agent
Am J Cardiol
(1978)
Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias
Br Heart J
(1980)
Amiodarone in refractory life-threatening ventricular arrhythmias
Ann Intern Med
(1983)
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation
N Engl J Med
(1981)
Cited by (0)
- ☆
This research was supported in part by a gift from Intec Systems, Inc., Pittsburgh, Pa.; and by an American Heart Association Medical Student Research Fellowship(Erie Fain).
Copyright © 1987 Published by Mosby, Inc.